A letter to the editor along with the author's reply are presented in response to the article "Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV - An Alternative View" by Michael A. Gillette, Bhavik M. Shah, Jason J. Schafer, and Joseph A. DeSimone, Jr.